Expansion rights get priced like everything else in a lease. Here is what a ROFO, a ROFR, a fixed option, and a must-take actually give you, what each one costs, and how to match the expansion mechanism to your growth plan.

By site 3 you have a prototype, written down or not. The question is who owns it, what it takes to change it, and whether you’ve documented well enough for the next architect to use it

Your second build runs on the same scarce resources as your first live clinic: attention, clinical leadership, and cash. How to structure decision rights, the prototype, and the cash model so the ramp and the build stop competing.

Your panel is spread across thirty states. Your first clinic serves a 25-minute drive radius. The patient heat map will point you to the wrong city — here are the four filters that find the right one.

Sites 3 through 6 decide whether your clinics compound or just accumulate. Density buys float pools, faster builds, and payer leverage. Spread buys the national story. Here's what each costs, and how to choose.

Site #2 is where healthcare founders learn whether they built a real system or just survived Site #1 through brute force. Here’s why expansion often slows momentum instead of compounding it.

Stop looking at real estate as a "location" problem. To scale a healthcare brand without bleeding cash, you need to view your expansion as a high-performance engine.